These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21448747)

  • 21. Evaluation of degradation pathways for plasmid DNA in pharmaceutical formulations via accelerated stability studies.
    Evans RK; Xu Z; Bohannon KE; Wang B; Bruner MW; Volkin DB
    J Pharm Sci; 2000 Jan; 89(1):76-87. PubMed ID: 10664540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buffer capacity of biologics--from buffer salts to buffering by antibodies.
    Karow AR; Bahrenburg S; Garidel P
    Biotechnol Prog; 2013; 29(2):480-92. PubMed ID: 23296746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles.
    Ahmed I; Day P
    Am J Hosp Pharm; 1987 Oct; 44(10):2287-90. PubMed ID: 3687969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements.
    Allwood MC; Stonkute D; Wallace A; Wilkinson AS; Hills T; Jamieson C;
    Eur J Hosp Pharm; 2020 Mar; 27(2):90-94. PubMed ID: 32153771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the myotoxicity of pharmaceutical buffers using an in vitro muscle model: effect of pH, capacity, tonicity, and buffer type.
    Napaporn J; Thomas M; Svetic KA; Shahrokh Z; Brazeau GA
    Pharm Dev Technol; 2000; 5(1):123-30. PubMed ID: 10669926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of formulation properties on chemical stability of captopril in aqueous preparations.
    Kristensen S; Lao YE; Brustugun J; Braenden JU
    Pharmazie; 2008 Dec; 63(12):872-7. PubMed ID: 19177902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme Immobilization on Metal Organic Frameworks: the Effect of Buffer on the Stability of the Support.
    Shortall K; Otero F; Bendl S; Soulimane T; Magner E
    Langmuir; 2022 Nov; 38(44):13382-13391. PubMed ID: 36286410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stability of irinotecan hydrochloride in aqueous solutions.
    Li WY; Koda RT
    Am J Health Syst Pharm; 2002 Mar; 59(6):539-44. PubMed ID: 11908247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photoprotection of daunorubicin hydrochloride with sodium sulfite.
    Islam MS; Asker AF
    PDA J Pharm Sci Technol; 1995; 49(3):122-6. PubMed ID: 7613990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cumulative effects of heat exposure and storage conditions of Oxytocin-in-Uniject in rural Ghana: implications for scale up.
    Mullany LC; Newton S; Afari-Asiedu S; Adiibokah E; Agyemang CT; Cofie P; Brooke S; Owusu-Agyei S; Stanton CK
    Glob Health Sci Pract; 2014 Aug; 2(3):285-94. PubMed ID: 25276588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stabilizing effect of citrate buffer on the photolysis of riboflavin in aqueous solution.
    Ahmad I; Sheraz MA; Ahmed S; Kazi SH; Mirza T; Aminuddin M
    Results Pharma Sci; 2011 May; 1(1):11-5. PubMed ID: 25755977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Photodegradation of oxytocin and thermal stability of photoproducts.
    Mozziconacci O; Schöneich C
    J Pharm Sci; 2012 Sep; 101(9):3331-46. PubMed ID: 22623074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-formulation and chemical stability studies of penethamate, a benzylpenicillin ester prodrug, in aqueous vehicles.
    Jain R; Wu Z; Bork O; Tucker IG
    Drug Dev Ind Pharm; 2012 Jan; 38(1):55-63. PubMed ID: 21696334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The modifications of the final stages of the complement reaction by alkali metal cations.
    Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
    J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of aqueous solutions of mibolerone.
    Amin MI; Koshy KT; Bryan JT
    J Pharm Sci; 1976 Dec; 65(12):1777-9. PubMed ID: 25955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-buffering antibody formulations.
    Gokarn YR; Kras E; Nodgaard C; Dharmavaram V; Fesinmeyer RM; Hultgen H; Brych S; Remmele RL; Brems DN; Hershenson S
    J Pharm Sci; 2008 Aug; 97(8):3051-66. PubMed ID: 18023013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preformulation studies of spironolactone: effect of pH, two buffer species, ionic strength, and temperature on stability.
    Pramar Y; Gupta VD
    J Pharm Sci; 1991 Jun; 80(6):551-3. PubMed ID: 1941547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preformulation studies for an ultrashort-acting neuromuscular blocking agent GW280430A. I. Buffer and cosolvent effects on the solution stability.
    Zhu H; Meserve K; Floyd A
    Drug Dev Ind Pharm; 2002; 28(2):135-42. PubMed ID: 11926357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degradation kinetics of mometasone furoate in aqueous systems.
    Teng XW; Cutler DC; Davies NM
    Int J Pharm; 2003 Jun; 259(1-2):129-41. PubMed ID: 12787642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
    Garidel P; Pevestorf B; Bahrenburg S
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.